| Literature DB >> 19366797 |
Geoffrey von Maltzahn1, Ji-Ho Park, Amit Agrawal, Nanda Kishor Bandaru, Sarit K Das, Michael J Sailor, Sangeeta N Bhatia.
Abstract
Plasmonic nanomaterials have the opportunity to considerably improve the specificity of cancer ablation by i.v. homing to tumors and acting as antennas for accepting externally applied energy. Here, we describe an integrated approach to improved plasmonic therapy composed of multimodal nanomaterial optimization and computational irradiation protocol development. We synthesized polyethylene glycol (PEG)-protected gold nanorods (NR) that exhibit superior spectral bandwidth, photothermal heat generation per gram of gold, and circulation half-life in vivo (t(1/2), approximately 17 hours) compared with the prototypical tunable plasmonic particles, gold nanoshells, as well as approximately 2-fold higher X-ray absorption than a clinical iodine contrast agent. After intratumoral or i.v. administration, we fuse PEG-NR biodistribution data derived via noninvasive X-ray computed tomography or ex vivo spectrometry, respectively, with four-dimensional computational heat transport modeling to predict photothermal heating during irradiation. In computationally driven pilot therapeutic studies, we show that a single i.v. injection of PEG-NRs enabled destruction of all irradiated human xenograft tumors in mice. These studies highlight the potential of integrating computational therapy design with nanotherapeutic development for ultraselective tumor ablation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19366797 PMCID: PMC2712876 DOI: 10.1158/0008-5472.CAN-08-4242
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701